BioXell S.p.A. insider transactions
Management transactions
0
Shareholding disclosures
18
First disclosure
21.06.2006
Last disclosure
13.03.2010
Company summary
No management purchase or sale disclosed in the last 90 days.
- Latest purchase
- —
- Net flow 90 d
- CHF 0.00
- Top shareholder
- 98.96%
—
Buys − sales
Cosmo Pharmaceuticals S. p.A
This page brings together all BioXell S.p.A. (BIOXELL) insider transactions: 0 management transactions and 18 significant shareholding disclosures published by SIX Exchange Regulation, from 21.06.2006 to 13.03.2010.
Detailed context
The insider24.ch page for BioXell S.p.A. shows 0 management transactions and 18 significant shareholding disclosures published by SIX Exchange Regulation. Over the last 90 days, there were 0 purchases and 0 sales totaling CHF 0, with no latest management transaction date recorded. The largest declared shareholders by voting rights include Cosmo Pharmaceuticals S.p.A at 98.96%, followed by INDEX Ventures II Deleware L.P, INDEX Ventures II GmbH & Co. KG, and INDEX Ventures II Jersey L.P, each holding 12.02%.
Insider barometer
90 days
No transaction in this window
Latest transaction
—
Largest purchase
—
Largest sale
—
These figures aggregate public disclosures. They are not investment advice.
insider24.ch
Follow BioXell S.p.A.’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
BioXell S.p.A. insider transactions
No management transaction disclosed for this company.
Latest shareholding disclosures
BioXell S.p.A.
LC Equity Fund, Ltd · Single shareholder
BioXell S.p.A.
Cosmo Pharmaceuticals S. p.A · Single shareholder
BioXell S.p.A.
BB Biotech AG · Single shareholder
BioXell S.p.A.
3V Asset Management AG · Single shareholder
BioXell S.p.A.
LC Equity Fund, Ltd · Single shareholder